Baseline characteristics
MAY
As depicted in the CONSORT flowchart, a total of 57 patients were randomized and exposed, of whom 50 (25 in each group) were enrolled and treated from December 2021 to May 2022 (Demographic characteristics, clinical data, and endocrine profile of the participants.AST, Astaxanthin group; BMI, Body Mass Index [weight (kg)/height (m2)]; AMH, Anti-müllerian Hormone; FSH, Follicle-stimulating Hormone; LH, Luteinizing Hormone; E2, Estradiol; P, Progesterone. Data are presented as mean ± SD. A P-value less than 0.05 is considered significant.